Schedule 13G ownership disclosure

ESSA PHARMA INC

Security class unavailable · CUSIP: 29668H708

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,298,662
Percent of class
5.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-001539
Form type
SC 13G
Filer
ESSA Pharma Inc.
CIK
CIK 1633932
Filed
Feb 14, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub